Export 6 results:
Filters: Author is Williams, David E  [Clear All Filters]
Journal Article
Maier MLVermilli, Siddens LK, Pennington J, Uesugi S, Anderson KA, Tidwell LG, Tilton SC, Ognibene TJ, Turteltaub K, Smith J et al..  2022.  Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [C]-BaP.. Environ Int. 159:107045.
Maier MLVermilli, Siddens LK, Pennington JM, Uesugi SL, Tilton SC, Vertel EA, Anderson KA, Tidwell LG, Ognibene TJ, Turteltaub KW et al..  2023.  Benzo[a]pyrene toxicokinetics in humans following dietary supplementation with 3,3'-diindolylmethane (DIM) or Brussels sprouts.. Toxicol Appl Pharmacol. :116377.
Teeguarden JG, Tan Y-M, Edwards SW, Leonard JA, Anderson KA, Corley RA, Kile M, Simonich SM, Stone D, Tanguay RL et al..  2016.  Completing the Link between Exposure Science and Toxicology for Improved Environmental Health Decision Making: The Aggregate Exposure Pathway Framework.. Environ Sci Technol. 50(9):4579-86.
Hummel JM, Madeen E, Siddens LK, Uesugi S, McQuistan T, Anderson KA, Turteltaub K, Ognibene TJ, Bench G, Krueger SK et al..  2018.  Pharmacokinetics of [C]-Benzo[a]pyrene (BaP) in humans: Impact of Co-Administration of smoked salmon and BaP dietary restriction.. Food Chem Toxicol. 115:136-147.
Crowell SRitger, Amin SG, Anderson KA, Krishnegowda G, Sharma AK, Soelberg JJ, Williams DE, Corley RA.  2011.  Preliminary physiologically based pharmacokinetic models for benzo[a]pyrene and dibenzo[def,p]chrysene in rodents.. Toxicol Appl Pharmacol. 257(3):365-76.
Madeen E, Siddens LK, Uesugi S, McQuistan T, Corley RA, Smith J, Waters KM, Tilton SC, Anderson KA, Ognibene TJ et al..  2019.  Toxicokinetics of benzo[a]pyrene in humans: Extensive metabolism as determined by UPLC-accelerator mass spectrometry following oral micro-dosing.. Toxicol Appl Pharmacol. 364:97-105.